CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
nifedipine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000530
NCT00000530Phase 3Completed
CompareCT.gov

Raynaud's Treatment Study (RTS)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 15, 2016

In Brief

A Phase 3 clinical trial evaluating nifedipine, biofeedback (psychology), and 1 other intervention for Cardiovascular Diseases and 3 related conditions. Completed.

Detailed Summary

To determine the relative efficacy of usual medical care and a course of treatment by thermal biofeedback in reducing vasospastic attacks characteristic of Raynaud's syndrome. Also, to confirm the frequency and severity of attacks, examine the role of psychophysiological factors in precipitating attacks, and assess the influence of treatment on health quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Raynaud's Disease, Vascular Diseases
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1992
Study CompletionJun 1, 1998
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

nifedipinedrug

biofeedback (psychology)behavioral

electromyographyprocedure